Cargando…

Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Death”

Detalles Bibliográficos
Autores principales:	Bezu, Lucillia, Gomes-da-Silva, Ligia C., Dewitte, Heleen, Breckpot, Karine, Fucikova, Jitka, Spisek, Radek, Galluzzi, Lorenzo, Kepp, Oliver, Kroemer, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450300/ https://www.ncbi.nlm.nih.gov/pubmed/26082782 http://dx.doi.org/10.3389/fimmu.2015.00275

Ejemplares similares

Combinatorial Strategies for the Induction of Immunogenic Cell Death
por: Bezu, Lucillia, et al.
Publicado: (2015)

Trial watch: Peptide-based vaccines in anticancer therapy
por: Bezu, Lucillia, et al.
Publicado: (2018)

Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
por: Fucikova, Jitka, et al.
Publicado: (2015)

Detection of immunogenic cell death and its relevance for cancer therapy
por: Fucikova, Jitka, et al.
Publicado: (2020)

Impact of local anesthetics on epigenetics in cancer
por: Bezu, Lucillia, et al.
Publicado: (2022)

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
por: Vanmeerbeek, Isaure, et al.
Publicado: (2020)

Calreticulin arms NK cells against leukemia
por: Fucikova, Jitka, et al.
Publicado: (2019)

Direct Cytotoxic and Indirect, Immune-Mediated Effects of Local Anesthetics Against Cancer
por: Wu Chuang, Alejandra, et al.
Publicado: (2022)

Immunogenic cell death in radiation therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Immunological Effects of Epigenetic Modifiers
por: Bezu, Lucillia, et al.
Publicado: (2019)

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
por: Fucikova, Jitka, et al.
Publicado: (2019)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021)

Immunogenic cell death in cancer: concept and therapeutic implications
por: Galluzzi, Lorenzo, et al.
Publicado: (2023)

Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
por: Gomes-da-Silva, Lígia C., et al.
Publicado: (2020)

Editorial: Anesthesia and cancer: Friend or foe?
por: Bezu, Lucillia, et al.
Publicado: (2022)

Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
por: Humeau, Juliette, et al.
Publicado: (2020)

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
por: Truxova, Iva, et al.
Publicado: (2023)

Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors
por: Kroemer, Guido, et al.
Publicado: (2016)

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

Mitochondrial regulation of cell death: a phylogenetically conserved control
por: Galluzzi, Lorenzo, et al.
Publicado: (2016)

Immunogenicity of cell death driven by immune effectors
por: Galluzzi, Lorenzo, et al.
Publicado: (2020)

Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus
por: Gomes-da-Silva, Lígia Catarina, et al.
Publicado: (2018)

Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
por: Wang, Yan, et al.
Publicado: (2020)

Identification of pharmacological agents that induce HMGB1 release
por: Liu, Peng, et al.
Publicado: (2017)

Identification of pharmacological inhibitors of conventional protein secretion
por: Zhao, Liwei, et al.
Publicado: (2018)

Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
por: Michaud, Mickaël, et al.
Publicado: (2014)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

A mitochondrial checkpoint to adaptive anticancer immunity
por: Kepp, Oliver, et al.
Publicado: (2023)

Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014)

Ferroptosis becomes immunogenic: implications for anticancer treatments
por: Tang, Daolin, et al.
Publicado: (2020)

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Kroemer, Guido, et al.
Publicado: (2021)

Trial watch: chemotherapy-induced immunogenic cell death in oncology
por: Sprooten, Jenny, et al.
Publicado: (2023)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

RNA-seq of macrophages of amoeboid or mesenchymal migratory phenotype due to specific structure of environment
por: Čermák, Vladimír, et al.
Publicado: (2018)

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
por: Kasikova, Lenka, et al.
Publicado: (2019)

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
por: Sukkurwala, Abdul Qader, et al.
Publicado: (2014)

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jqmj6cs6v0lblaujhmqouh9sfm